Syndax Pharmaceuticals Inc (SNDX)
19.27
-0.02
(-0.10%)
USD |
NASDAQ |
May 31, 16:00
19.25
-0.02
(-0.10%)
After-Hours: 20:00
Syndax Pharmaceuticals Cash from Investing (TTM): -1.705M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -1.705M |
December 31, 2023 | 117.61M |
September 30, 2023 | -3.73M |
June 30, 2023 | -50.60M |
March 31, 2023 | -174.46M |
December 31, 2022 | -186.19M |
September 30, 2022 | -108.52M |
June 30, 2022 | -75.09M |
March 31, 2022 | -3.463M |
December 31, 2021 | -40.87M |
September 30, 2021 | -45.06M |
June 30, 2021 | -52.41M |
March 31, 2021 | -152.70M |
December 31, 2020 | -142.53M |
September 30, 2020 | -71.79M |
June 30, 2020 | -78.70M |
March 31, 2020 | -19.02M |
December 31, 2019 | 12.78M |
September 30, 2019 | 22.15M |
June 30, 2019 | 13.29M |
March 31, 2019 | 51.51M |
Date | Value |
---|---|
December 31, 2018 | 51.40M |
September 30, 2018 | 36.99M |
June 30, 2018 | 40.40M |
March 31, 2018 | -15.44M |
December 31, 2017 | -17.07M |
September 30, 2017 | 2.806M |
June 30, 2017 | 3.936M |
March 31, 2017 | 39.87M |
December 31, 2016 | -18.28M |
September 30, 2016 | -57.27M |
June 30, 2016 | -72.73M |
March 31, 2016 | -89.32M |
December 31, 2015 | -61.67M |
September 30, 2015 | -46.21M |
June 30, 2015 | -38.80M |
March 31, 2015 | -19.05M |
December 31, 2014 | 1.888M |
September 30, 2014 | -0.064M |
June 30, 2014 | -0.072M |
March 31, 2014 | -2.575M |
December 31, 2013 | -4.027M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-186.19M
Minimum
Dec 2022
117.61M
Maximum
Dec 2023
-52.05M
Average
-47.83M
Median
Cash from Investing (TTM) Benchmarks
Geron Corp | 32.62M |
Verastem Inc | -12.66M |
Karyopharm Therapeutics Inc | 62.27M |
Crinetics Pharmaceuticals Inc | -248.86M |
Arvinas Inc | -62.90M |